Quest Diagnostics Launches Dementia Diagnostic Blood Test For Treatable Causes Of Cognitive Impairment (OPEN MINDS Weekly News Wire Book 2013)

Price: ₹210.04
(as of Aug 08, 2023 16:52:36 UTC – Details)

Quest Diagnostics launched sales of a clinical blood test panel for diagnosing dementia due to secondary, treatable causes of cognitive impairment. The company believes it is the first commercial service to combine several guideline-recommended tests for identifying secondary, treatable causes of dementia as a single blood test and report. Sales began in March 2013…

ASIN ‏ : ‎ B00DZW8IUO
Publisher ‏ : ‎ Behavioral Health Industry News, Inc. d/b/a OPEN MINDS; July 17, 2013 edition (15 July 2013)
Language ‏ : ‎ English
File size ‏ : ‎ 349 KB
Text-to-Speech ‏ : ‎ Enabled
Screen Reader ‏ : ‎ Supported
Enhanced typesetting ‏ : ‎ Enabled
X-Ray ‏ : ‎ Not Enabled
Word Wise ‏ : ‎ Not Enabled
Print length ‏ : ‎ 3 pages